CLINICAL_TRIALS
trial_result
· 2021-04-27
Clinical Trial Update: Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC [Phase 2]
Summary
Phase II trial of pembrolizumab with palliative radiotherapy in metastatic breast cancer was terminated; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Metastatic Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2021-04-27